Found: 74
Select item for more details and to access through your institution.
Blood neurofilament light chain measurements in adults with CNS histiocytic neoplasms.
- Published in:
- 2024
- By:
- Publication type:
- Letter
U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00922-7
- By:
- Publication type:
- Article
The immunome of mobilized peripheral blood stem cells is predictive of long-term outcomes and therapy-related myeloid neoplasms in patients with multiple myeloma undergoing autologous stem cell transplant.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00920-9
- By:
- Publication type:
- Article
Bilateral Intrusion of Molar using Modified transpalatal Arch in Mutilated Case.
- Published in:
- Journal of Indian Orthodontic Society, 2014, v. 48, n. 4, p. 280, doi. 10.1177/0974909820140411
- By:
- Publication type:
- Article
NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and human.
- Published in:
- Journal of Clinical Investigation, 2011, v. 121, n. 4, p. 1456, doi. 10.1172/JCI43242
- By:
- Publication type:
- Article
Clinicopathologic correlates and prognostic impact of lymphoid aggregates in patients with myelodysplastic syndromes.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 4, p. 1627, doi. 10.1111/bjh.19677
- By:
- Publication type:
- Article
Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1232, doi. 10.1111/bjh.19325
- By:
- Publication type:
- Article
TP53 variant allele frequency and therapy‐related setting independently predict survival in myelodysplastic syndromes with del(5q).
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1243, doi. 10.1111/bjh.19247
- By:
- Publication type:
- Article
The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 2, p. 279, doi. 10.1111/bjh.18850
- By:
- Publication type:
- Article
Classical and non‐classical phenotypes of Erdheim–Chester disease: Correlating clinical, radiographic and genotypic findings.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 3, p. 454, doi. 10.1111/bjh.18422
- By:
- Publication type:
- Article
Limited activity of fedratinib in myelofibrosis patients relapsed/refractory to ruxolitinib 20 mg twice daily or higher: A real‐world experience.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 4, p. e54, doi. 10.1111/bjh.18284
- By:
- Publication type:
- Article
Mimics of Erdheim–Chester disease.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 4, p. 984, doi. 10.1111/bjh.17949
- By:
- Publication type:
- Article
Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 5, p. 1004, doi. 10.1111/bjh.17423
- By:
- Publication type:
- Article
Characteristics of patients with myelodysplastic syndrome with balanced translocations.
- Published in:
- British Journal of Haematology, 2020, v. 190, n. 2, p. 244, doi. 10.1111/bjh.16551
- By:
- Publication type:
- Article
Sensitive PCR‐based monitoring and early detection of relapsed JAK2 V617F myelofibrosis following transplantation.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 5, p. 831, doi. 10.1111/bjh.15059
- By:
- Publication type:
- Article
Efficacy of biological agents in the treatment of Erdheim‐Chester disease.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 3, p. 520, doi. 10.1111/bjh.14997
- By:
- Publication type:
- Article
Adult disseminated Langerhans cell histiocytosis: incidence, racial disparities and long‐term outcomes.
- Published in:
- British Journal of Haematology, 2018, v. 182, n. 4, p. 579, doi. 10.1111/bjh.14818
- By:
- Publication type:
- Article
Use of sublingual tacrolimus in adults undergoing hematopoietic cell transplant: A pilot study.
- Published in:
- Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 2, p. 387, doi. 10.1177/1078155221995230
- By:
- Publication type:
- Article
Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 5, p. 871, doi. 10.1002/ajh.27263
- By:
- Publication type:
- Article
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. E63, doi. 10.1002/ajh.27180
- By:
- Publication type:
- Article
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 2, p. 193, doi. 10.1002/ajh.27138
- By:
- Publication type:
- Article
TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo‐Moffitt study of 156 informative cases.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. E76, doi. 10.1002/ajh.26845
- By:
- Publication type:
- Article
Reduced intensity conditioning allogeneic hematopoietic stem cell transplantation in VEXAS syndrome: Data from a prospective series of patients.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. E28, doi. 10.1002/ajh.26786
- By:
- Publication type:
- Article
A dynamic 3‐factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 9, p. 1127, doi. 10.1002/ajh.26630
- By:
- Publication type:
- Article
Outcomes following venetoclax‐based treatment in therapy‐related myeloid neoplasms.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. 1013, doi. 10.1002/ajh.26589
- By:
- Publication type:
- Article
Real‐world experience with venetoclax and hypomethylating agents in myelodysplastic syndromes with excess blasts.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 6, p. E214, doi. 10.1002/ajh.26539
- By:
- Publication type:
- Article
A population‐based study of acute panmyelosis with myelofibrosis in the United States: 2004–2015.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. E144, doi. 10.1002/ajh.26467
- By:
- Publication type:
- Article
Midostaurin therapy for indolent and smoldering systemic mastocytosis: Retrospective review of Mayo Clinic experience.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 4, p. E138, doi. 10.1002/ajh.26464
- By:
- Publication type:
- Article
Sustained, complete response to pexidartinib in a patient with CSF1R‐mutated Erdheim–Chester disease.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 293, doi. 10.1002/ajh.26441
- By:
- Publication type:
- Article
A population‐based study of outcomes in polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the United States from 2001 to 2015: Comparison with data from a Mayo Clinic single institutional series.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. E464, doi. 10.1002/ajh.26377
- By:
- Publication type:
- Article
Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: Staging, natural history, and comparative survival.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. 1604, doi. 10.1002/ajh.26355
- By:
- Publication type:
- Article
Single‐agent cladribine as an effective front‐line therapy for adults with Langerhans cell histiocytosis.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 5, p. E146, doi. 10.1002/ajh.26119
- By:
- Publication type:
- Article
Neurological Manifestations of Histiocytic Disorders.
- Published in:
- Current Neurology & Neuroscience Reports, 2023, v. 23, n. 6, p. 277, doi. 10.1007/s11910-023-01272-4
- By:
- Publication type:
- Article
Clonal heterogeneity in STAG2m myeloid neoplasms: the Mayo Clinic experience.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Temporal trends in critical care utilization and outcomes in allogeneic hematopoietic stem cell transplant recipients.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 3, p. 957, doi. 10.1007/s00277-023-05612-9
- By:
- Publication type:
- Article
Co-mutational pattern of somatic GATA2-mutated myeloid neoplasms.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 1, p. 211, doi. 10.1007/s00277-022-05016-1
- By:
- Publication type:
- Article
Autoimmune manifestations in STAG2-mutated myeloid neoplasms.
- Published in:
- Annals of Hematology, 2022, v. 101, n. 12, p. 2785, doi. 10.1007/s00277-022-04995-5
- By:
- Publication type:
- Article
Impact of marrow blasts percentage on high-grade myelodysplastic syndrome assessed using revised international prognostic scoring system.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Single-Antibody Evaluation of T-Cell Receptor β Constant Chain Monotypia by Flow Cytometry Facilitates the Diagnosis of T-Cell Large Granular Lymphocytic Leukemia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Never Say Die: Survival Signaling in Large Granular Lymphocyte Leukemia.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, p. S244, doi. 10.3816/CLM.2009.s.019
- By:
- Publication type:
- Article
Emerging role of CEBP-α mutations in acute myeloid leukemia.
- Published in:
- 2015
- By:
- Publication type:
- Editorial
Epigenetic therapy overcomes treatment resistance in T cell prolymphocytic leukemia.
- Published in:
- Science Translational Medicine, 2015, v. 7, n. 293, p. 1, doi. 10.1126/scitranslmed.aaa5079
- By:
- Publication type:
- Article
TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00821-x
- By:
- Publication type:
- Article
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00818-6
- By:
- Publication type:
- Article
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00812-y
- By:
- Publication type:
- Article
TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00821-x
- By:
- Publication type:
- Article
Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome.
- Published in:
- 2023
- By:
- Publication type:
- Letter
Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- Published in:
- 2023
- By:
- Publication type:
- Letter
Clinical and therapeutic implications of BRAF fusions in histiocytic disorders.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00693-7
- By:
- Publication type:
- Article
Clinical outcome of myelodysplastic syndrome progressing on hypomethylating agents with evolving frontline therapies: continued challenges and unmet needs.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00691-9
- By:
- Publication type:
- Article